Nuclear Medicine and Biology
Volume 36, Issue 5 , Pages 505-513 , July 2009

Development of high-specific-activity 68Ga-labeled DOTA-rhenium-cyclized α-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors

  • Melchor V. Cantorias

      Affiliations

    • University of Missouri Research Reactor Center (MURR), Columbia, MO 65211, USA
    • ,
  • Said D. Figueroa

      Affiliations

    • Department of Radiology, University of Missouri, Columbia, MO 65212, USA
    • Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • ,
  • Thomas P. Quinn

      Affiliations

    • Department of Biochemistry, University of Missouri, Columbia, MO 65211, USA
    • Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • ,
  • John R. Lever

      Affiliations

    • Department of Radiology, University of Missouri, Columbia, MO 65212, USA
    • Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • ,
  • Timothy J. Hoffman

      Affiliations

    • Department of Radiology, University of Missouri, Columbia, MO 65212, USA
    • ,
  • Lisa D. Watkinson

      Affiliations

    • Department of Radiology, University of Missouri, Columbia, MO 65212, USA
    • Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • ,
  • Terry L. Carmack

      Affiliations

    • Department of Radiology, University of Missouri, Columbia, MO 65212, USA
    • Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • ,
  • Cathy S. Cutler

      Affiliations

    • University of Missouri Research Reactor Center (MURR), Columbia, MO 65211, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 573 882 5211; fax: +1 573 882 6671.

Received 30 October 2008 ,Revised 26 January 2009 ,Accepted 31 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(09)00043-2

doi: 10.1016/j.nucmedbio.2009.01.017

Nuclear Medicine and Biology
Volume 36, Issue 5 , Pages 505-513 , July 2009

Article Tools

* Image Usage & Resolution